You are here

Biblio

[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Butkiewicz M, Blue EE, Leung YYee, Jian X, Marcora E, Renton AE, Kuzma A, San Wang L-, Koboldt DC, Haines JL et al..  2018.  Functional annotation of genomic variants in studies of late-onset Alzheimer's disease.. Bioinformatics. 34(16):2724-2731.
Butkiewicz M, Haines JL, Bush WS.  2017.  Introducing COCOS: codon consequence scanner for annotating reading frame changes induced by stop-lost and frame shift variants.. Bioinformatics. 33(10):1561-1562.
Bussies PL, Rajabli F, Griswold A, Dorfsman DA, Whitehead P, Adams LD, Mena PR, Cuccaro M, Haines JL, Byrd GS et al..  2020.  Use of local genetic ancestry to assess -523' and risk for Alzheimer disease.. Neurol Genet. 6(2):e404.
Bush WS, Wheeler N, Beaulieu-Jones B, Darabos C.  2020.  Packaging Biocomputing Software to Maximize Distribution and Reuse.. Pac Symp Biocomput. 25:739-742.
Broce IJ, Tan CHong, Fan CChieh, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM et al..  2019.  Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.. Acta Neuropathol. 137(2):209-226.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
Breuza L, Arighi CN, Argoud-Puy G, Casals-Casas C, Estreicher A, Famiglietti MLivia, Georghiou G, Gos A, Gruaz-Gumowski N, Hinz U et al..  2020.  A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.. J Alzheimers Dis. 77(1):257-273.
Bressler J, Marioni RE, Walker RM, Xia R, Gottesman RF, B Windham G, Grove ML, Guan W, Pankow JS, Evans KL et al..  2019.  Epigenetic Age Acceleration and Cognitive Function in African-American Adults in Midlife: The Atherosclerosis Risk in Communities Study.. J Gerontol A Biol Sci Med Sci.
Braggin JE, Bucks SA, Course MM, Smith CL, Sopher B, Osnis L, Shuey KD, Domoto-Reilly K, Caso C, Kinoshita C et al..  2019.  Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.. Ann Clin Transl Neurol. 6(4):762-777.
Blue EE, Yu C-E, Thornton TA, Chapman NH, Kernfeld E, Jiang N, Shively KM, Buckingham KJ, Marvin CT, Bamshad MJ et al..  2018.  Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease.. Genes Brain Behav. 17(6):e12429.
Blue EE, Horimoto ARVR, Mukherjee S, Wijsman EM, Thornton TA.  2019.  Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics.. Alzheimers Dement. 15(12):1524-1532.
Blue EE, Cheng A, Chen S, Yu C-E.  2020.  Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.. JAMA Netw Open. 3(10):e2017666.
Blue EE, Bis JC, Dorschner MO, Tsuang DW, Barral SM, Beecham G, Below JE, Bush WS, Butkiewicz M, Cruchaga C et al..  2018.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.. Dement Geriatr Cogn Disord. 45(1-2):1-17.
Blue EE, Thornton TA, Kooperberg C, Liu S, Wactawski-Wende J, Manson JA, Kuller L, Hayden K, Reiner AP.  2021.  Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women.. Alzheimers Dement. 17(2):215-225.
Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE et al..  2018.  Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.. Mol Psychiatry.
Bentley AR, Sung YJ, Brown MR, Winkler TW, Kraja AT, Ntalla I, Schwander K, Chasman DI, Lim E, Deng X et al..  2019.  Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.. Nat Genet. 51(4):636-648.
Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD.  2020.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.. JAMA Neurol. 77(7):849-862.
Beer JC, Tustison NJ, Cook PA, Davatzikos C, Sheline YI, Shinohara RT, Linn KA.  2020.  Longitudinal ComBat: A method for harmonizing longitudinal multi-scanner imaging data.. Neuroimage. 220:117129.
Beecham GW, Bis JC, Martin ER, Choi S-H, DeStefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE et al..  2017.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.. Neurol Genet. 3(5):e194.
Beecham GW, Vardarajan B, Blue E, Bush W, Jaworski J, Barral S, DeStefano A, Hamilton-Nelson K, Kunkle B, Martin ER et al..  2018.  Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease.. Neurol Genet. 4(6):e286.
Barral S, Cheng R, Reitz C, Vardarajan B, Lee J, Kunkle B, Beecham G, Cantwell LS, Pericak-Vance MA, Farrer LA et al..  2015.  Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease.. Alzheimers Dement. 11(12):1397-1406.
Baker E, Sims R, Leonenko G, Frizzati A, Harwood JC, Grozeva D, Morgan K, Passmore P, Holmes C, Powell J et al..  2019.  Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.. PLoS One. 14(7):e0218111.
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen C-Y, Carrasquillo MM, Allen M et al..  2021.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.. PLoS Genet. 17(1):e1009224.
Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, Hwang P, Chan AT, Graves SM, Uweru JO et al..  2020.  Negative feedback control of neuronal activity by microglia.. Nature. 586(7829):417-423.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer